Sign in
BRTX Stock Price, Chart, Stats & News
BioRestorative Therapies, Inc.
Save
3.59M
Market cap
–
Current P/E
–
Forward P/E
BRTX chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 64.05% |
Operating margin | -4350.05% |
Pretax margin | -3959.40% |
Net margin | -3959.40% |
Effective tax rate | – |
ROA | -349.10% |
ROE | -420.31% |
D/E | – |
Interest coverage ratio | – |
BRTX valuation
P/E | – |
P/S | 7.33x |
P/B | 7.39x |
P/CF | -0.24x |
P/FCF | -0.24x |
P/OCF | -0.24x |
PEG | 0.02x |
EV multiple | -0.29x |
About
BioRestorative Therapies, Inc. is a life sciences company dedicated to developing regenerative medicine products and therapies. Their approach primarily utilizes adult stem cell protocols to address two key areas: disc/spine disease and metabolic disorders. Within their disc/spine program, known as brtxDisc, the company's leading cell therapy candidate is BRTX-100.
Similar securities
Based on sector and market capitalization
Report issue